Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) saw a large decrease in short interest in the month of December. As of December 31st, there was short interest totalling 5,350,000 shares, a decrease of 23.1% from the December 15th total of 6,960,000 shares. Based on an average trading volume of 1,560,000 shares, the short-interest ratio is […]